What does SANIFAR do?

SANIFAR is a logistics company in Gent. Private Limited, started on 31 August 1983, 1 establishment.

What is the address of SANIFAR?

The registered office of SANIFAR is located at Lourdesstraat 43, 9041 Gent.

Is SANIFAR still active?

Yes. According to the CBE (29 October 2026) SANIFAR is active, legal situation “Normale toestand”, started on 31 August 1983.

Is SANIFAR registered on Peppol?

Yes, SANIFAR is registered on the Peppol network with ID 0208:0424456756.

What is the enterprise number of SANIFAR?

The enterprise number of SANIFAR is BE0424456756.

When was SANIFAR founded?

SANIFAR was founded on 31 August 1983.

Who are the directors of SANIFAR?

According to the 2025 annual accounts, the directors of SANIFAR are: Sodiap BV, Alexo BV.

Is SANIFAR a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 31 August 1983; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did SANIFAR make in 2025?

SANIFAR posted a profit after taxes of € 49,219 in financial year 2025.

What is the revenue of SANIFAR?

As a small company, SANIFAR is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 343,664.

How much does an employee at SANIFAR earn?

The average wage cost per full-time employee at SANIFAR was € 55,100 in 2025: staff costs of € 253,513 for 4.6 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does SANIFAR have?

According to the 2025 annual accounts, SANIFAR has 4.6 full-time equivalents (FTE).

SANIFAR (Private Limited) - Gent - BE0424456756

Dossier SANIFAR, printed on 29 October 2026 from databakkes.be/en/0424456756/sanifar. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

SANIFAR from Gent, company number BE0424456756, closed financial year 2025 with a result of € 49,219 after tax. For that financial year SANIFAR recorded a gross margin of € 343,664 and equity of € 1.1 million. Compared with financial year 2024, the result moved from € 49,692 to € 49,219. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 12, 2026.

What it is worth Growing

€ 1.1 million

▲ 5% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 49,219

▼ 1% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 13,993

▼ 25% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 1 million.

People and assets in 2025

Full-time equivalents

4.6

▲ 1 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 253,513

▲ 56% vs 2024

€ 55,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 5,917

▲ 7% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 117,414

▼ 37% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 40,811

▲ 43% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 237,779 Gross margin 2022: € 237,779 First fiscal year in the series	€ 293,544 Gross margin 2023: € 293,544 ▲ 23% vs 2022 (€ 237,779) Favourable step	€ 246,299 Gross margin 2024: € 246,299 ▼ 16% vs 2023 (€ 293,544) Unfavourable step	€ 343,664 Gross margin 2025: € 343,664 ▲ 40% vs 2024 (€ 246,299) Favourable step	▲ 40%
Profit after taxes	€ 57,400 Profit after taxes 2022: € 57,400 First fiscal year in the series	€ 44,843 Profit after taxes 2023: € 44,843 ▼ 22% vs 2022 (€ 57,400) Unfavourable step	€ 49,692 Profit after taxes 2024: € 49,692 ▲ 11% vs 2023 (€ 44,843) Favourable step	€ 49,219 Profit after taxes 2025: € 49,219 ▼ 1% vs 2024 (€ 49,692) Unfavourable step	▼ 1%
Equity	€ 2,036,906 Equity 2022: € 2,036,906 First fiscal year in the series	€ 983,749 Equity 2023: € 983,749 ▼ 52% vs 2022 (€ 2,036,906) Unfavourable step	€ 1,033,441 Equity 2024: € 1,033,441 ▲ 5% vs 2023 (€ 983,749) Favourable step	€ 1,082,660 Equity 2025: € 1,082,660 ▲ 5% vs 2024 (€ 1,033,441) Favourable step	▲ 5%
Total debts	€ 172,250 Total debts 2022: € 172,250 First fiscal year in the series	€ 207,694 Total debts 2023: € 207,694 ▲ 21% vs 2022 (€ 172,250) Unfavourable step	€ 213,973 Total debts 2024: € 213,973 ▲ 3% vs 2023 (€ 207,694) Unfavourable step	€ 158,225 Total debts 2025: € 158,225 ▼ 26% vs 2024 (€ 213,973) Favourable step	▼ 26%
Cash	€ 20,395 Cash 2022: € 20,395 First fiscal year in the series	€ 18,858 Cash 2023: € 18,858 ▼ 8% vs 2022 (€ 20,395) Unfavourable step	€ 18,625 Cash 2024: € 18,625 ▼ 1% vs 2023 (€ 18,858) Unfavourable step	€ 13,993 Cash 2025: € 13,993 ▼ 25% vs 2024 (€ 18,625) Unfavourable step	▼ 25%
Land & buildings	€ 209,321 Land & buildings 2022: € 209,321 First fiscal year in the series	€ 192,988 Land & buildings 2023: € 192,988 ▼ 8% vs 2022 (€ 209,321) Unchanged	€ 169,040 Land & buildings 2024: € 169,040 ▼ 12% vs 2023 (€ 192,988) Unchanged	€ 145,092 Land & buildings 2025: € 145,092 ▼ 14% vs 2024 (€ 169,040) Unchanged	▼ 14%
Retained profit	€ 1,999,753 Retained profit 2022: € 1,999,753 First fiscal year in the series	€ 946,597 Retained profit 2023: € 946,597 ▼ 53% vs 2022 (€ 1,999,753) Unfavourable step	€ 996,289 Retained profit 2024: € 996,289 ▲ 5% vs 2023 (€ 946,597) Favourable step	€ 1,045,508 Retained profit 2025: € 1,045,508 ▲ 5% vs 2024 (€ 996,289) Favourable step	▲ 5%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 1,098,000 Dividend 2023: € 1,098,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 1,098,000) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 2,209,156 Balance sheet total 2022: € 2,209,156 First fiscal year in the series	€ 1,191,443 Balance sheet total 2023: € 1,191,443 ▼ 46% vs 2022 (€ 2,209,156) Unchanged	€ 1,247,414 Balance sheet total 2024: € 1,247,414 ▲ 5% vs 2023 (€ 1,191,443) Unchanged	€ 1,240,885 Balance sheet total 2025: € 1,240,885 ▼ 1% vs 2024 (€ 1,247,414) Unchanged	▼ 1%
Employees (FTE)	2.6 Employees (FTE) 2022: 2.6 First fiscal year in the series	3.6 Employees (FTE) 2023: 3.6 ▲ 1 vs 2022 (2.6) Unchanged	3.6 Employees (FTE) 2024: 3.6 Unchanged (3.6) Unchanged	4.6 Employees (FTE) 2025: 4.6 ▲ 1 vs 2024 (3.6) Unchanged	▲ 1

Key figures of SANIFAR, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to SANIFAR?

What happened at SANIFAR in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 12, 2026 New annual accounts for financial year 2025: profit of € 49,219 (▼ 1% vs 2024). Source: NBB ↗
2022 Alexo BV became a director. NBB
2020 Sodiap BV became a director. NBB
Sep 9, 1983 New establishment in Gent. KBO
Aug 31, 1983 Start of the company according to the CBE. KBO

In short

From € 57,400 profit in 2022 to € 49,219 profit in 2025.

Paid € 78,525 in corporate taxes since 2022.

Best year ever: 2022, with € 57,400 profit.

On average € 74,700 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

SODIAP 100%

The stake of SODIAP comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

SANIFAR

Behind SANIFAR are Sodiap BV and Alexo BV. The shares are held by SODIAP (100%).

Directors

According to the 2025 annual accounts

Sodiap BV

Managing director · represented by Tom Goderis

Also active at: SDC, HC Pharma, APOTHEEK JENNE, Apotheek de Lisseweg, Apotheek Seurinck, APOTHEEK SCARPHOUT, C.E. FARMA, WENDUINE PHARMA +24 more

since 2020

Alexo BV

Chairman of the board · represented by Olivier Delaere

Also active at: SDC, HC Pharma, SODIAP, APOTHEEK JENNE, PANNOC CHEMIE, Apotheek de Lisseweg, Apotheek Seurinck, APOTHEEK SCARPHOUT +34 more

since 2022

Shareholders

SODIAP

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Lourdesstraat 43

9041 Gent

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0424.456.756

VAT number

BE 0424.456.756

Registered office

Lourdesstraat 43, 9041 Gent

Names & denominations

SANIFAR

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

31 August 1983

Peppol

Active · Active since 6 Jun 2025

Activities · NACE

Apothekers

Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗

SANIFAR

Financials

What happened to SANIFAR?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions